LabCompass

Felipe F. Lamenza

Medicine · The Ohio State University

Established · publishing since 1996Rising activity

Publications

21

Citations

165

Est. group size

~2

Recurring co-author estimate

Active years

31

Publishing since 1996

Research summary
AI-generated

Felipe F. Lamenza's work touches on cancer biology (including immune-related aspects and cell signaling pathways), as well as topics such as chondroitin sulfate's role in venous thrombosis. The available data is limited, but suggests a research profile spanning molecular cancer mechanisms and vascular biology. Prospective students should note that the public bibliographic record for this researcher is sparse, so this profile only reflects a partial picture of their work.

Cancer immunotherapy and biomarkersImmune cell functionCancer-related molecular mechanismsCell signaling in cancer (PI3K/AKT/mTOR pathway)Vascular biology and thrombosis

Publication output began around 2021 and has grown modestly since, averaging about 3.2 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.2/year recently
171819202021: 2 publications212022: 2 publications222023: 5 publications5232024: 3 publications242025: 4 publications252026: 2 publications26
Recent publications
Publishes in
  • Oral Oncology×2
  • The Journal of Immunology×1
  • British Journal of Cancer×1
  • Carcinogenesis×1
  • Frontiers in Immunology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile